Cutting edge: Ly49C/I neonatal NK cells predispose newborns to autoimmune ovarian disease induced by maternal autoantibody

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 2865-2869

  Rival, Claudia ^a   Samy, Eileen ^a,b   Setiady, Yulius ^a,c   Tung, Kenneth ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c IMMUNOGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE OVARY DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; OVARY DISEASE; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; OVARIAN DISEASES; PREGNANCY;

EID: 84884225491     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301500     Document Type: Article

References (27)

1. UNICEF. 2009. The State of the World's Children 2009: Maternal and Newborn Health. United Nations Children's Fund, New York.
2. Lindop, R., G. Arentz, L. A. Thurgood, J. H. Reed, M. W. Jackson, and T. P. Gordon. 2012. Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol. Cell Biol. 90: 304-309.
3. Wang, L., D. Zhou, J. Lee, H. Niu, T. W. Faust, S. Frattini, C. Kowal, P. T. Huerta, B. T. Volpe, and B. Diamond. 2012. Female mouse fetal loss mediated by maternal autoantibody. J. Exp. Med. 209: 1083-1089.
4. Gardnerova, M., B. Eymard, E. Morel, M. Faltin, J. Zajac, O. Sadovsky, P. Tripon, M. Domergue, B. Vernet-der Garabedian, and J. F. Bach. 1997. The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology 48: 50-54.
5. Silva, D. G., S. R. Daley, J. Hogan, S. K. Lee, C. E. Teh, D. Y. Hu, K. P. Lam, C. C. Goodnow, and C. G. Vinuesa. 2011. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 60: 2102-2111.
6. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. Actively acquired tolerance of foreign cells. Nature 172: 603-606.
7. Zaghouani, H., C. M. Hoeman, and B. Adkins. 2009. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 30: 585-591.
8. Garza, K. M., N. D. Griggs, and K. S. K. Tung. 1997. Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: requirement of endogenous neonatal ovaries. Immunity 6: 89-96.
9. Setiady, Y. Y., E. T. Samy, and K. S. K. Tung. 2003. Maternal autoantibody triggers de novo T cell-mediated neonatal autoimmune disease. J. Immunol. 170: 4656-4664.
10. Setiady, Y. Y., P. Pramoonjago, and K. S. K. Tung. 2004. Requirements of NK cells and proinflammatory cytokines in T cell-dependent neonatal autoimmune ovarian disease triggered by immune complex. J. Immunol. 173: 1051-1058.
11. Samy, E. T., K. M. Wheeler, R. J. Roper, C. Teuscher, and K. S. K. Tung. 2008. Cutting edge: autoimmune disease in day 3 thymectomized mice is actively controlled by endogenous disease-specific regulatory T cells. J. Immunol. 180: 4366-4370.
12. Lou, Y., J. Ang, H. Thai, F. McElveen, and K. S. K. Tung. 1995. A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. J. Immunol. 155: 2715-2720.
13. Nimmerjahn, F., and J. V. Ravetch. 2011. FcgRs in health and disease. Curr. Top. Microbiol. Immunol. 350: 105-125.
14. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252.
15. Guarda, G., C. Dostert, F. Staehli, K. Cabalzar, R. Castillo, A. Tardivel, P. Schneider, and J. Tschopp. 2009. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460: 269-273.
16. Elliott, J. M., and W. M. Yokoyama. 2011. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 32: 364-372.
17. Dorfman, J. R., and D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187: 609-618.
18. Kubota, A., S. Kubota, S. Lohwasser, D. L. Mager, and F. Takei. 1999. Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163: 212-216.
19. Ortaldo, J. R., R. Winkler-Pickett, and G. Wiegand. 2000. Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors. J. Leukoc. Biol. 68: 748-756.
20. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
21. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
22. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. "Unlicensed" natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
23. Tarek, N., J. B. Le Luduec, M. M. Gallagher, J. Zheng, J. M. Venstrom, E. Chamberlain, S. Modak, G. Heller, B. Dupont, N. K. Cheung, and K. C. Hsu. 2012. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J. Clin. Invest. 122: 3260-3270.
24. Barreira da Silva, R., and C. Münz. 2011. Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell. Mol. Life Sci. 68: 3505-3518.
25. Shi, F. D., and Q. Zhou. 2011. Natural killer cells as indispensable players and therapeutic targets in autoimmunity. Autoimmunity 44: 3-10.
26. Schleinitz, N., F. Vély, J. R. Harlé, and E. Vivier. 2010. Natural killer cells in human autoimmune diseases. Immunology 131: 451-458.
27. Shi, F. D., H. B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H. G. Ljunggren. 2000. Natural killer cells determine the outcome of B cellmediated autoimmunity. Nat. Immunol. 1: 245-251.